Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENOCHIAN BIOSCIENCES, INC.

(ENOB)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Logo Enochian Biosciences, Inc.
Enochian BioSciences Inc. is a pre-clinical stage biotechnology company. The Company uses its cell, gene and immune therapy technologies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, as well as to provide cancer remission in some of the deadliest cancers. The CompanyÔÇÖs product candidates include ENOB-HV-01, an autologous transplant with genetically modified cells; ENOB-HV-11 and ENOB-HV-12, preventive and therapeutic vaccines; ENOB-HV-21, immunotherapy with allogeneic NK/GDT cells; ENOB-HV-31, in Vivo gene therapy; ENOB-HB-01, potential cure for HBV; ENOB-CV-01, Aerosol/Inhaled treatment potentially for all Coronaviruses that cause human disease; ENOB-CV-11, Aerosol/Inhaled prophylaxis potentially for all coronaviruses that cause human disease; ENOB-FL-01 Aerosol/Inhaled treatment potentially for all influenza viruses; and ENOB-FL-11, Aerosol/Inhaled prophylaxis potentially for all influenza viruses.

Number of employees : 11 people.
Managers
Name Title Age Since
Mark Richard Dybul, Dr. Executive Vice Chairman & Chief Executive Officer 56 2021
Luisa Puche Chief Financial Officer 57 -
Joseph R. Cohen, Dr. Director-Research & Discovery - -
Carl Sandler Independent Director 47 2018
James Sapirstein Independent Director 58 2018
Carol L. Brosgart, Dr. Independent Director 68 -
Gregg Alton Independent Director 54 -
Jayne McNicol Independent Director - 2021
Members of the board
Name Title Age Since
Rene Sindlev Chairman 58 2017
Henrik S°rensen Director 47 2017
Mark Richard Dybul, Dr. Executive Vice Chairman & Chief Executive Officer 56 2021
Carl Sandler Independent Director 47 2018
James Sapirstein Independent Director 58 2018
Carol L. Brosgart, Dr. Independent Director 68 -
Gregg Alton Independent Director 54 -
Jayne McNicol Independent Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,219,661 20,117,218 38.5% 0 0.0% 38.5%
Shareholders
NameEquities%
Carl Sandler 13,259,533 25.4%
Serhat Gumrukcu 10,446,171 20.0%
Rs Group ApS 9,668,351 18.5%
Sabby Capital LLC 1,341,663 2.57%
The Vanguard Group, Inc. 265,200 0.51%
Geode Capital Management LLC 148,059 0.28%
Millennium Management LLC 116,666 0.22%
Dimensional Fund Advisors LP 80,825 0.15%
Virtu Financial BD LLC 68,007 0.13%
Mark Richard Dybul 66,196 0.13%
Company contact information
Enochian Biosciences, Inc.
2080 Century Park East
Suite 906
Los Angeles, CA 90067-2012

Phone : +1.305.918.1980
Web : http://www.enochianbio.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Enochian Biosciences, Inc.
Sector Bio Therapeutic Drugs